EphB4 Antibody (5G2F8): sc-130081
- EphB4 Antibody (5G2F8) is a mouse monoclonal IgG1 κ, cited in 7 publications, provided at 200 µg/ml
- raised against a recombinant protein corresponding to amino acids 771-987 of EphB4 of human origin
- recommended for detection of EphB4 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
- m-IgG Fc BP-HRP and m-IgG1 BP-HRP are the preferred secondary detection reagents for EphB4 Antibody (5G2F8) for WB and IHC(P) applications. These reagents are now offered in bundles with EphB4 Antibody (5G2F8) (see ordering information below).
EphB4 Antibody (5G2F8) is a mouse monoclonal IgG1 antibody that detects EphB4 in mouse, rat, and human samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). EphB4 is a member of the Eph receptor family, which is the largest group of receptor protein tyrosine kinases identified to date, and plays a crucial role in mediating cell-cell interactions during developmental processes. EphB4 is primarily located on the cell surface, where EphB4 interacts with ephrin-B2 to regulate cellular signaling pathways that influence cell migration, adhesion, and tissue organization. Proper functioning of EphB4 is vital for vascular development and the formation of the nervous system, as EphB4 helps guide the growth of blood vessels and neuronal connections. Dysregulation of EphB4 signaling has been implicated in various diseases, including cancer, making EphB4 an important target for therapeutic intervention. Anti-EphB4 antibody (5G2F8) provides a reliable tool for researchers studying these critical biological processes and the underlying mechanisms of related pathologies.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
EphB4 Antibody (5G2F8) References:
- EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells. | Chen, K., et al. 2015. J Cell Biochem. 116: 467-75. PMID: 25359705
- EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer. | Lv, J., et al. 2016. Exp Mol Pathol. 100: 402-8. PMID: 27072105
- EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease. | Yang, D., et al. 2016. Angiogenesis. 19: 297-309. PMID: 27216867
- EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF. | Groppa, E., et al. 2018. EMBO Rep. 19: PMID: 29643120
- EphB4 mediates resistance to antiangiogenic therapy in experimental glioma. | Uhl, C., et al. 2018. Angiogenesis. 21: 873-881. PMID: 29987450
- Transcriptional and Post-Translational Control Mechanisms for EphB4 Expression in Physiology and Cancer Disease. | Scalia, P., et al. 2021. Crit Rev Eukaryot Gene Expr. 31: 83-88. PMID: 34347982
- Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake. | Xu, C., et al. 2023. Oncogene. 42: 99-112. PMID: 36376513
- EphB4 monomer inhibits chronic graft vasculopathy in an aortic transplant model. | Langford, JT., et al. 2023. JVS Vasc Sci. 4: 100109. PMID: 37519335
- Biological Significance of EphB4 Expression in Cancer. | Ullah, A., et al. 2024. Curr Protein Pept Sci. 25: 244-255. PMID: 37909437
- An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves. | Chen, D., et al. 2023. bioRxiv.. PMID: 38045382
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
EphB4 Antibody (5G2F8) | sc-130081 | 200 µg/ml | $316.00 | |||
EphB4 Antibody (5G2F8): m-IgG Fc BP-HRP Bundle | sc-539808 | 200 µg Ab; 10 µg BP | $354.00 | |||
EphB4 Antibody (5G2F8): m-IgG1 BP-HRP Bundle | sc-541722 | 200 µg Ab; 20 µg BP | $354.00 |